Xcout Intel
Grünenthal
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Subscribe to see Grünenthal’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Grünenthal at a glance
Grünenthal is a pharmaceuticals company headquartered in Germany. Xcout tracks 8 named people at Grünenthal, including Fabian Raschke (Fabian Raschke).
Grünenthal leadership
- Fabian RaschkeFabian Raschke
- Gabriel BaertschiGabriel Baertschi
- Jan AdamsJan Adams
- Leen HofkensLeen Hofkens
- Quentin Le Masne de ChermontQuentin Le Masne de Chermont
- Sebastian KöhlerSebastian Köhler
2 more named people on record for Grünenthal, with roles, board committees and tenure — see the full roster →
Get Grünenthal's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Grünenthal in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access